Phase II studies on prostate cancer

This publication has 35 references indexed in Scilit:

• Representation of older patients in cancer treatment trials
  Cancer, 1994
• Mitomycin C Versus Estramustine in the Treatment of Hormone Resistant Metastatic Prostate Cancer: Thefinal Analysis of the European Organization Forresearch and Treatment of Cancer, Genitourinarygroup Prospective Randomized Phase III Study (30865)
  Journal of Urology, 1993
• The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer
  Journal of Urology, 1993
• Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade
  Urology, 1993
• Characterization of Localized Prostatic Cancer: Distribution, Grading and Pt-Staging in Radical Prostatectomy Specimens
  Scandinavian Journal of Urology and Nephrology, 1993
• Mitomycin-C in the treatment of metastatic prostate cancer: report on an EORTC phase II study
  World Journal of Urology, 1986
• Can the primary tumour be used as the sole parameter for response in phase II chemotherapy studies in metastatic prostate cancer? An EORTC Genito-Urinary Group Report
  World Journal of Urology, 1986
• Transrectal ultrasonometry of the prostate: the prognostic relevance of volume changes under endocrine management
  World Journal of Urology, 1986
• Treatment response criteria for prostatic cancer
  The Prostate, 1984
• A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II
  Cancer, 1979